$16.290
-0.182 (-1.12%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AUPH Prediction & Forecast by Similar Chart Analysis
Alphio's AUPH stock price prediction model matches the current Aurinia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.19 (-0.60%). The 1-week path is $17.25 (+5.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aurinia Pharmaceuticals Inc. Stock?
Aurinia Pharmaceuticals is a good buy right now due to its strong financial performance, including a gross margin of 92.12% in Q2 2026, and a recent increase in net income by 74% year-over-year, reaching $37.4 million. The stock has also shown resilience with a 39.47% increase over the past year, indicating strong market confidence. However, a notable risk is the current RSI of 50.785, which suggests the stock is neither overbought nor oversold, indicating potential volatility ahead.
AUPH stock price ended at $16.29 on Friday, after losing -1.12%
Aurinia Pharmaceuticals Inc. (AUPH) last closed at $16.29, losing -1.12%. These facts feed the 1-day and 1-week AUPH price prediction above.
Analyst Consensus
Aurinia Pharmaceuticals Inc. (AUPH): 5 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Aurinia Pharmaceuticals Inc. (AUPH) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AUPH, ranked by similarity.
Seasonality analysis for AUPH
Historically the probability of a positive August return for AUPH is 55.56%. December offers the highest probability of a positive month at 97.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AUPH
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $7.89 | $10.40 | $12.51 | -36.13% |
| Sep 2026 | $6.83 | $8.39 | $9.13 | -48.52% |
| Oct 2026 | $8.01 | $8.39 | $10.06 | -48.52% |
| Nov 2026 | $10.17 | $10.27 | $10.48 | -36.95% |
| Dec 2026 | $8.27 | $10.11 | $12.60 | -37.93% |
In 2026, Aurinia Pharmaceuticals Inc. (AUPH) is projected to range from $6.83 to $12.60.
Aurinia Pharmaceuticals Inc. 2026 monthly forecast
In Aug 2026, Aurinia Pharmaceuticals Inc. is projected to average $10.40, with a low of $7.89 and high of $12.51.
In Sep 2026, Aurinia Pharmaceuticals Inc. is projected to average $8.39, with a low of $6.83 and high of $9.13.
In Oct 2026, Aurinia Pharmaceuticals Inc. is projected to average $8.39, with a low of $8.01 and high of $10.06.
In Nov 2026, Aurinia Pharmaceuticals Inc. is projected to average $10.27, with a low of $10.17 and high of $10.48.
In Dec 2026, Aurinia Pharmaceuticals Inc. is projected to average $10.11, with a low of $8.27 and high of $12.60.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.